1. Home
  2. IH vs BYSI Comparison

IH vs BYSI Comparison

Compare IH & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$1.40

Market Cap

70.5M

Sector

Real Estate

ML Signal

HOLD

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

N/A

Current Price

$1.61

Market Cap

58.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IH
BYSI
Founded
1996
2010
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.5M
58.4M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
IH
BYSI
Price
$1.40
$1.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.3K
18.8K
Earning Date
03-31-2026
05-13-2026
Dividend Yield
5.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$1.18
52 Week High
$3.60
$2.50

Technical Indicators

Market Signals
Indicator
IH
BYSI
Relative Strength Index (RSI) 39.45 48.68
Support Level N/A $1.56
Resistance Level $1.84 $1.83
Average True Range (ATR) 0.09 0.09
MACD -0.01 -0.01
Stochastic Oscillator 15.17 22.73

Price Performance

Historical Comparison
IH
BYSI

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

Share on Social Networks: